Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies
18 janv. 2022 10h52 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Jan. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022
12 janv. 2022 09h56 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Jan. 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF),a comprehensive medical diagnostics and related solutions company,...
Todos Medical CEO to Appear on Fox Business to Talk COVID Testing & Tollovir on Tuesday, January 11, 2022 and is Presenting at Biotech Showcase 2022
10 janv. 2022 14h06 HE
|
Todos Medical Ltd.
“COVID Testing: What Needs to Happen Now to Turn the Corner in 2022” CEO blog released New York, NY, and Tel Aviv, ISRAEL, Jan. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd....
Todos Medical CEO Provides Letter to Shareholders
05 janv. 2022 18h04 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Jan. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company,...
Todos Medical to Present at January 5, 2022 Emerging Growth Conference
03 janv. 2022 08h30 HE
|
Todos Medical Ltd.
NEW YORK, NY and TEL AVIV, Israel, Jan. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
Todos Medical Records Record Weekly COVID PCR Testing Volumes at Provista
27 déc. 2021 09h01 HE
|
Todos Medical Ltd.
cPass neutralizing antibody testing seeing increasing demand, questions of infection-acquired immunity, vaccine-acquired immunity and booster shot durability emerge The Company also entered into a...
Todos Medical CEO to Appear on Yahoo Finance Live! at 12:10PM EST with Akiko Fujita to Talk Pfizer’s Paxlovid Approval, Tollovir™ Phase 2 & COVID Testing
23 déc. 2021 07h37 HE
|
Todos Medical Ltd.
CEO Gerald Commissiong is also scheduled to appear on BNC at 1:50PM EST to discuss the authorization of Pfizer’s COVID antiviral drug & Tollovir™ Phase 2 for hospitalized COVID New York, NY,...
Todos Medical Announces New cPass Neutralizing Antibody Testing Reference Lab Agreement for CLIA/CAP Lab Provista with Physician Group in 40 States
22 déc. 2021 09h56 HE
|
Todos Medical Ltd.
§ Provista completed validation for fingerprick At-Home sample collection of blood for the cPass neutralizing antibody test New York, NY, and Tel Aviv, ISRAEL, Dec. 22, 2021 (GLOBE NEWSWIRE)...
Todos Medical Appoints Valentino Smith, MBA as Vice President of Marketing
20 déc. 2021 07h30 HE
|
Todos Medical Ltd.
Company retains iiiNTENT SAAS artificial intelligence marketing service for Tollovid® and Tollovid Daily™ 3CL protease inhibitor dietary supplement products NEW YORK, NY and TEL AVIV, Israel , Dec....
Todos Medical Announces “Test & Tollovid®” Holiday Package for Atlanta Area at Provista Diagnostics
17 déc. 2021 08h51 HE
|
Todos Medical Ltd.
New York, NY, and Tel Aviv, ISRAEL, Dec. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...